Dianthus 制药 DNTH
$86.03 +$3.02 (+3.64%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $88.00 +2.29%
开盘$84.12
昨收$83.01
当日区间$82.13 – $87.44
成交量595.3K
市值$4.84B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$761,000.00+294.3% YoY
营业利润-$61.48M-76.0% YoY
净利润-$50.22M-58.8% YoY
摊薄每股收益-$0.90-2.3% YoY
自由现金流-$49.16M-105.4% YoY
经营现金流-$48.98M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-11,441.4%
净利率-10,097.0%
净资产收益率-26.1%
资产收益率-25.0%
投入资本回报率-29.6%
流动比率26.10
负债/资产比率3.4%
现金及投资$886.81M
总负债$913,000.00
净现金（净负债）$885.90M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $761,000.00 | $463,000.00 | $2.04M | $284,000.00 | $396,000.00 |
| 营业总收入 | $761,000.00 | $463,000.00 | $2.04M | $284,000.00 | $396,000.00 |
| 营业费用 | $62.24M | $47.00M | $179.97M | $69.83M | $40.68M |
| 销售及管理费用 | $13.56M | $12.47M | $34.33M | $9.93M | $8.20M |
| -管理费用 | $13.56M | $12.47M | $34.33M | $9.93M | $8.20M |
| 研发费用 | $48.69M | $34.53M | $145.64M | $59.90M | $32.49M |
| 营业利润 | -$61.48M | -$46.53M | -$177.93M | -$69.54M | -$40.29M |
| 非经营性利息净收入（支出） | $11.54M | $6.27M | $16.12M | $5.27M | $3.66M |
| 非经营性利息收入 | $11.54M | $6.27M | $16.12M | $5.27M | $3.66M |
| 其他收入（支出） | -$275,000.00 | -$566,000.00 | -$523,000.00 | -$158,000.00 | -$135,000.00 |
| 证券出售收益 | $95,000.00 | -$317,000.00 | $451,000.00 | $251,000.00 | $225,000.00 |
| 其他非经营性收入（支出） | -$370,000.00 | -$249,000.00 | -$974,000.00 | -$409,000.00 | -$360,000.00 |
| 税前利润 | -$50.22M | -$40.83M | -$162.34M | -$64.43M | -$36.77M |
| 净利润 | -$50.22M | -$40.83M | -$162.34M | -$64.43M | -$36.77M |
| 持续经营利润 | -$50.22M | -$40.83M | -$162.34M | -$64.43M | -$36.77M |
| 归属母公司净利润 | -$50.22M | -$40.83M | -$162.34M | -$64.43M | -$36.77M |
| 归属普通股股东净利润 | -$50.22M | -$40.83M | -$162.34M | -$64.43M | -$36.77M |
| 基本每股收益 | -$0.90 | -$0.85 | -$4.20 | -$1.43 | -$0.97 |
| 摊薄每股收益 | -$0.90 | -$0.85 | -$4.20 | -$1.43 | -$0.97 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.21B | $1.25B | $530.92M | $530.92M | $577.45M |
| 流动资产合计 | $897.54M | $1.12B | $409.44M | $409.44M | $413.83M |
| 现金及现金等价物与短期投资 | $886.81M | $1.11B | $404.30M | $404.30M | $402.61M |
| -现金及现金等价物 | $110.55M | $627.67M | $51.09M | $51.09M | $55.98M |
| -短期投资 | $776.26M | $483.59M | $353.21M | $353.21M | $346.63M |
| 应收款 | $106,000.00 | $1.23M | $52,000.00 | $52,000.00 | $5.00M |
| -应收账款 | $106,000.00 | $1.23M | $52,000.00 | $52,000.00 | $5.00M |
| 预付资产 | $10.43M | $7.34M | $5.01M | $5.01M | $6.14M |
| 其他流动资产 | $184,000.00 | $83,000.00 | $86,000.00 | $86,000.00 | $73,000.00 |
| 非流动资产合计 | $315.73M | $126.97M | $121.48M | $121.48M | $163.62M |
| 固定资产净值 | $1.64M | $1.57M | $1.63M | $1.63M | $1.49M |
| -固定资产原值 | $2.01M | $1.90M | $1.94M | $1.94M | $1.77M |
| -累计折旧 | -$373,000.00 | -$336,000.00 | -$304,000.00 | -$304,000.00 | -$277,000.00 |
| 投资及预付款 | $303.63M | $113.87M | $110.14M | $110.14M | $152.87M |
| -可供出售证券 | $303.63M | $113.87M | $110.14M | $110.14M | $152.87M |
| 其他非流动资产 | $10.46M | $11.54M | $9.72M | $9.72M | $9.26M |
| 负债合计 | $41.25M | $45.57M | $37.52M | $37.52M | $30.99M |
| 流动负债合计 | $34.39M | $38.28M | $30.73M | $30.73M | $23.86M |
| 应付款 | $6.39M | $5.27M | $9.73M | $9.73M | $6.71M |
| -应付账款 | $6.39M | $5.27M | $9.73M | $9.73M | $6.71M |
| 一年内应计费用 | $20.49M | $28.43M | $9.94M | $9.94M | $9.31M |
| 短期债务及融资租赁负债 | $374,000.00 | $399,000.00 | $367,000.00 | $367,000.00 | $217,000.00 |
| -一年内到期融资租赁负债 | $374,000.00 | $399,000.00 | $367,000.00 | $367,000.00 | $217,000.00 |
| 一年内递延负债 | $1.52M | $1.49M | $1.19M | $1.19M | $954,000.00 |
| 非流动负债合计 | $6.86M | $7.29M | $6.79M | $6.79M | $7.14M |
| 长期债务及融资租赁负债 | $913,000.00 | $965,000.00 | $1.02M | $1.02M | $1.07M |
| -长期融资租赁负债 | $913,000.00 | $965,000.00 | $1.02M | $1.02M | $1.07M |
| 一年以上递延负债 | $5.94M | $6.32M | $5.77M | $5.77M | $6.07M |
| 股东权益合计 | $1.17B | $1.20B | $493.40M | $493.40M | $546.45M |
| 股东权益 | $1.17B | $1.20B | $493.40M | $493.40M | $546.45M |
| 股本 | $55,000.00 | $54,000.00 | $43,000.00 | $43,000.00 | $43,000.00 |
| -普通股 | $55,000.00 | $54,000.00 | $43,000.00 | $43,000.00 | $43,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.60B | $1.58B | $829.60M | $829.60M | $818.55M |
| 留存收益 | -$427.78M | -$377.56M | -$336.73M | -$336.73M | -$272.30M |
| 不影响留存收益的损益 | -$2.13M | -$575,000.00 | $489,000.00 | $489,000.00 | $163,000.00 |
| -一年内应收关联方款项 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$48.98M | -$28.86M | -$129.06M | -$46.98M | -$30.56M |
| 持续经营经营活动现金流净额 | -$48.98M | -$28.86M | -$129.06M | -$46.98M | -$30.56M |
| 持续经营净利润 | -$50.22M | -$40.83M | -$162.34M | -$64.43M | -$36.77M |
| 持续经营损益 | -$105,000.00 | $302,000.00 | -$507,000.00 | -$253,000.00 | -$227,000.00 |
| 折旧、折耗与摊销 | $107,000.00 | $76,000.00 | $428,000.00 | $97,000.00 | $99,000.00 |
| 营运资金变动 | -$5.01M | $2.22M | $16.73M | $12.48M | $2.86M |
| -应收款变动 | $1.12M | -$1.18M | $755,000.00 | $4.95M | -$4.96M |
| -预付资产变动 | -$3.20M | -$2.33M | -$235,000.00 | $1.12M | -$35,000.00 |
| -应付账款及应计费用变动 | -$3.78M | $7.00M | $11.28M | $6.68M | $3.00M |
| -其他流动资产变动 | $1.18M | -$2.12M | $358,000.00 | -$207,000.00 | $89,000.00 |
| -其他营运资金变动 | -$339,000.00 | $849,000.00 | $4.57M | -$64,000.00 | $4.76M |
| 投资活动现金流净额 | -$478.52M | -$133.97M | -$122.83M | $37.20M | -$201.28M |
| 持续经营投资活动现金流净额 | -$478.52M | -$133.97M | -$122.83M | $37.20M | -$201.28M |
| 资本支出 | -$181,000.00 | -$10,000.00 | -$213,000.00 | -$138,000.00 | -$5,000.00 |
| 投资购置及出售净额 | -$478.34M | -$133.96M | -$122.62M | $37.34M | -$201.27M |
| 筹资活动现金流 | $10.38M | $739.41M | $280.13M | $4.88M | $274.51M |
| 持续经营筹资活动现金流净额 | $10.38M | $739.41M | $280.13M | $4.88M | $274.51M |
| 普通股发行净额 | $0.00 | $736.36M | $272.27M | $0.00 | $272.27M |
| 股票期权行使所得 | $10.58M | $4.40M | $8.22M | $5.08M | $2.42M |
| 其他筹资费用净额 | -$201,000.00 | -$1.34M | -$364,000.00 | -$192,000.00 | – |
| 期末现金余额 | $110.72M | $627.84M | $51.25M | $51.25M | $56.15M |
| 现金净变动 | -$517.12M | $576.58M | $28.23M | -$4.90M | $42.68M |
| 期初现金余额 | $627.84M | $51.25M | $23.02M | $56.15M | $13.47M |
| 自由现金流 | -$49.16M | -$28.87M | -$129.27M | -$47.12M | -$30.56M |
暂无评论——快来第一个聊聊 DNTH。